Form 4 for FHTX Foghorn Therapeutics Inc.
Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-14 · accession 0001562180-21-007735 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-16 | 2021-12-14 | FHTX | KADOCH CIGALL | Dir, 10% | G - Gift | $0.00 | -333.3K | 295.0K | -53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-14 | G | D | 333,333 | $0.00 | 295,000 | D | — | — | (F1) On December 14, 2021, the Reporting Person transferred 333,333 shares of Common Stock to the Cigall Kadoch Irrevocable Trust of 2021 (the "Irrevocable Trust"). The Reporting Person is not a trustee of the Irrevocable Trust and she exercises no investment discretion with respect to trust property therein. The Reporting Person and members of her immediate family are beneficiaries of the Irrevocable Trust. |